A Phase 1 Trial of X-396, a Novel ALK Inhibitor, in Patients With Advanced Solid Tumors
Horn, L., Blumenscheine, G., Wakelee, H.A., Arkenau, T.H., Dukart, G., Harrow, K., Liang, C., Gibbons, J.J., Lovly, C.M., Infante, J.R.Volume:
90
Language:
english
Journal:
International Journal of Radiation Oncology*Biology*Physics
DOI:
10.1016/j.ijrobp.2014.08.251
Date:
November, 2014
File:
PDF, 82 KB
english, 2014